58
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Multielectrode phased radiofrequency ablation compared with point-by-point ablation for pulmonary vein isolation – outcomes in 539 patients

, , , , , , & show all
Pages 11-20 | Published online: 16 Jan 2014

References

  • Camm AJ, Kirchhof P, Lip GY, et al; European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369–2429.
  • Kirchhof P, Auricchio A, Bax J, et al. Outcome parameters for trials in atrial fibrillation: executive summary. Eur Heart J. 2007;28(22):2803–2817.
  • Lip GY, Golding DJ, Nazir M, Beevers DG, Child DL, Fletcher RI. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract. 1997;47(418):285–289.
  • Knecht S, Hocini M, Wright M, et al. Left atrial linear leasions are required for successful treatment of persistent atrial fibrillation. Eur Heart J. 2008;29(19):2359–2366.
  • Boersma LV, Wijffels MC, Oral H, Wever EF, Morady F. Pulmonary vein isolation by duty-cycled bipolar and unipolar radiofrequency energy with a multielectrode ablation catheter. Heart Rhythm. 2008;5(12):1635–1642.
  • Spitzer SG, Karolyi L. Catheter ablation of atrial fibrilliaton – current status and future directions. Applied Cardiopulmonary Pathophysiology. 2009;13:291–299.
  • Wieczorek M, Hoeltgen R, Akin E, Salili AR, Oral H, Morady F. Results of short-term and long-term pulmonary vein isolation for paroxysmal atrial fibrillation using duty-cycled bipolar and unipolar radiofrequency energy. J Cardiovasc Electrophysiol. 2010;21(4):399–405.
  • Scharf C, Boersma L, Davies W, et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol. 2009;54(15):1450–1456.
  • Bulava A, Haniš J, Sitek D, et al. Catheter ablation for paroxysmal atrial fibrillation: a randomized comparison between multielectrode catheter and point-by-point ablation. Pacing Clin Electrophysiol. 2010;33(9):1039–1046.
  • Bittner A, Mönnig G, Zellerhoff S, et al. Randomized study comparing duty-cycled bipolar and unipolar radiofrequency with point-by-point ablation in pulmonary vein isolation. Heart Rhythm. 2011;8(9):1383–1390.
  • World Medical Association. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. Amended by the 59th World Medical Association General Assembly, Seoul, October 2008. Ferney-Voltaire, France: World Medical Association; 2008. Available from: http://www.wma.net/en/30publications/10policies/b3/index.html.pdf. Accessed June 8, 2013.
  • Tada H, Oral H, Sticherling C, et al. Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol. 2001;38(3):750–755.
  • European Heart Rhythm Association (EHRA), European Cardiac Arrhythmia Society (ECAS), American College of Cardiology (ACC), et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816–861.
  • Gaita F, Caponi D, Pianelli M, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122(17):1667–1673.
  • Andrade JG, Dubuc M, Rivard L, et al. Efficacy and safety of atrial fibrillation ablation with phased radiofrequency energy and multielectrode catheters. Heart Rhythm. 2012;9(2):289–296.
  • Mulder AA, Wijffels MC, Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy:2-year follow-up and predictors of failure. Europace. 2012;14(6):818–825.
  • Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160–166.
  • Mulder AA, Balt JC, Wijffels MC, Wever EF, Boersma LV. Safety of pulmonary vein isolation and left atrial complex fractioned atrial electrograms ablation for atrial fibrillation with phased radiofrequency energy and multi-electrode catheters. Europace. 2012;14(10):1433–1440.
  • Tivig C, Dang L, Brunner-La Rocca HP, özcan S, Duru F, Scharf C. Duty-cycled unipolar/bipolar versus conventional radiofrequency ablation in paroxysmal and persistent atrial fibrillation. Int J Cardiol. 2012;157(2):185–191.
  • Wijffels MC, Van Oosterhout M, Boersma LV, et al. Characterization of in vitro and in vivo lesions made by a novel multichannel ablation generator and a circumlinear decapolar ablation catheter. J Cardiovasc Electrophysiol. 2009;20(10):1142–1148.
  • Beukema RJ, Elvan A, Smit JJ, Delnoy PP, Misier AR, Reddy V. Pulmonary vein isolation to treat paroxysmal atrial fibrillation: conventional versus multi-electrode radiofrequency ablation. J Interv Card Electrophysiol. 2012;34(2):143–152.
  • Khaykin Y, Zarnett L, Friedlander D, et al. Point-by-point pulmonary vein antrum isolation guided by intracardiac echocardiography and 3D mapping and duty-cycled multipolar AF ablation: effect of multipolar ablation on procedure duration and fluoroscopy time. J Interv Card Electrophysiol. 2012;34(3):303–310.
  • Karolyi L, Otto T, Rämmler C, Kadalie CT, Spitzer SG. Singlecentererfahrung mit der NavX-gestützten linksatrialen Substratmodifikation bei Patienten mit Vorhofflimmern [Single-centre experience with NavX-supported left atrial substrate modification in patients with atrial fibrillation]. Clin Res Cardiol Suppl. 2008;3(1):113–117. German.
  • von Bary C, Weber S, Dornia C, et al. Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter (PVAC). Circ Arrhythm Electrophysiol. 2011;4(5):630–636.
  • Hegland D, Piccini JP, Goldstein LB, Daubert JP. Cerebral magnetic resonance findings in asymptomatic patients after atrial fibrillation catheter ablation: cause for alarm or further study? J Cardiovasc Electrophysiol. 2011;22(9):969–972.
  • Gaita F, Leclercq JF, Schumacher B, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol. 2011;22(9):961–968.
  • Herrera Siklódy C, Deneke T, Hocini M, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58(7):681–688.
  • Steinberg JS, Mittal S. Intracranial emboli associated with catheter ablation of atrial fibrillation: has the silence finally been broken? J Am Coll Cardiol. 2011;58(7):689–691.
  • Scharf C, Ng GA, Wieczorek M, et al. European survey on efficacy and safety of duty-cycled radiofrequency ablation for atrial fibrillation. Europace. 2012;14(12):1700–1707.
  • Cappato R, Calkins H, Chen SA, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38.
  • Oral H, Chugh A, Ozaydin M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation. 2006;114(8):759–765.
  • Sakamoto T, Kumagai K, Nishiuchi S, et al. Predictors of asymptomatic cerebral infarction associated with radiofrequency catheter ablation for atrial fibrillation using an irrigated-tip catheter. Europace. 2013;15(3):332–338.
  • Verma A, Debruyne P, Nardi S, et al; ERACE Investigators. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol. 2013;6(5):835–842.
  • Medtronic Atrial Fibrillation Solutions. PRECISION GOLD Post Market Study in Europe of Pulmonary Vein Ablation Catheter (PVAC GOLD). Available from: http://clinicaltrials.gov/show/NCT01767558. NLM identifier: NCT01767558. Accessed December 6, 2013.
  • Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40(1):84–92.
  • Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606.
  • Mulder AA, Wijffels MC, Wever EF, Kelder JC, Boersma LV. Arrhythmia detection after atrial fibrillation ablation: value of incremental monitoring time. Pacing Clin Electrophysiol. 2012;35(2):164–169.